Author:
Volpe Donna A.,Hamed Salaheldin S.,Zhang Lei K.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Balimane PV, Marino A, Chong S. P-gp inhibition potential in cell-based models: which “calculation” method is the most accurate? AAPS J. 2008;10:577–86.
2. Food and Drug Administration (2012). Draft guidance. Guidance for industry: drug interaction studies—study design, data analysis, and implications for dosing and labeling. Available from http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm . Accessed 28 October 2013.
3. European Medicine Agency. Guideline on the investigation of drug interactions. 2012. http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500129606&mid=WC0b01ac058009a3dc . Accessed 28 October 2013.
4. Han HK. Role of transporters in drug interactions. Arch Pharmacol Res. 2011;34:1865–77.
5. Balimane PV, Han YH, Chong S. Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J. 2006; 8(1):article 1.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献